文献速递介入腹部CTMRUSDSA

肝细胞癌的肝脏导向治疗

Liver-directed therapy for hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

本文综述肝细胞癌的肝脏导向治疗方式,包括经皮影像引导消融、经动脉化疗栓塞和经动脉放射栓塞,由介入放射科医生实施;根据疾病分期选择单一或联合治疗模式以达到最佳疗效,并关注各疗法的疗效与患者选择标准。

要点

  • 肝脏导向治疗是肝细胞癌治疗策略的关键组成部分。
  • 治疗方式包括经皮影像引导消融、经动脉化疗栓塞和经动脉放射栓塞。
  • 根据疾病分期选择单一或联合治疗模式,关注疗效与患者选择标准。

核心结论

  • 肝脏导向治疗是肝细胞癌治疗策略的关键组成部分,需根据疾病分期选择单一或联合治疗模式以达到最佳疗效。

研究设计与样本

  • 综述,检索范围与纳入文献原文未报告。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Liver-directed therapy is a critical component of treatment strategies for hepatocellular carcinoma. These therapies included percutaneous image-guided ablation, transarterial chemoembolization, and transarterial radioembolization, and are administered by interventional radiologists. Depending on the stage of disease, a particular treatment modality, or a combination thereof, is expected to be most efficacious in achieving the goals of treatment for a particular patient. This article seeks to review the various liver-directed treatment modalities for treatment of hepatocellular carcinoma, with attention to their efficacy and patient selection criteria.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Narsinh KH, Duncan DP, Newton IG, et al. Liver-directed therapy for hepatocellular carcinoma. Abdom Radiol (NY). 2018. PMID: 29230556. doi:10.1007/s00261-017-1435-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。